SlideShare ist ein Scribd-Unternehmen logo
1 von 46
Downloaden Sie, um offline zu lesen
Theerapan Songnuy M.D.
Overview
 Definition
 Etiology
 Diagnosis
 Conclusion
Occupational Asthma ( OA)
Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition. 939-953.
-A type of asthma caused by the workplace
-Classified into 2 types:
1. OA with a latency period need to get
sensitized to an agent in the workplace
2. OA without a latency period, occur after
accidentally inhale at work
-Of the first type, mostly caused by high ( protein)
molecular-weight agents
-High-molecular weight agent induced by IgE-
mediated mechanism
- LMW agents act as hapten
Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition.
939-953.
l
Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition. 939-953.
JACI 2013; 131: 704-10
Aims
1. Compare the clinical , functional and inflammatory
characteristics of workers with work-exacerbated
asthma and occupational asthma
2. Compare health care use and related costs between
work-exacerbated asthma and occupational asthma,
work-related asthma and non-work-related asthma
JACI 2013; 131: 704-10
Materials & Methods
 A prospective cohort study with a 2-year follow-
up
 Subjects:
- Asthmatic patients referred for suspected
work-related asthma
- Two tertiary centers in Quebec, Canada
- From 2003-2008
JACI 2013; 131: 704-10
Materials & Methods
 Subjects :
- At first visit ; questionnaires, SPT, PFT,
methacholine inhalation challenge test,
sputum induction
- Be classified as ; inflammatory phenotypes
- Eosiophilic ( sputum EO > 3%)
- Nutrophilic ( sputum N > 61%)
- Paucigranulocytic ( sputum EO< 3%,N < 61%)
- Mixed ( sputum EO> 3% , N > 61%)
Materials & Methods
 Severe asthma: an ER visit or a hospitalization
 Specific inhalation challenges to occupational agents
were done when asthma possibly related to work
 Asthma diagnosis:
- FEV1<80% of predicted value
- FEV1/FVC < 0.7
- improvement in FEV1 > 12% after bronchodilator
- If absence of reversible airflow limitation,
PC20 value should < 16 mg/ml
JACI 2013; 131: 704-10
Materials & Methods
 Diagnosis of occupational asthma:
- Positive specific inhalation challenge test
- Worsening asthma symptoms while at work
Diagnosis of work-exacerbation asthma:
- Negative specific inhalation challenge test
- Worsening asthma symptoms while at work
Materials & Methods
 Health care use and related costs
- From administrative database
- Focusing on physician’s cost, ER visit &
hospitalization
JACI 2013; 131: 704-10
JACI 2013; 131: 704-10
JACI 2013; 131: 704-10
JACI 2013; 131: 704-10
JACI 2013; 131: 704-10
JACI 2013; 131: 704-10
Conclusion
 Workers with WEA have more severe clinical
than workers with occupational asthma
 WEA is associated with a non-eosinophilic
phenotype
 Both WEA & occupational asthma have
greater health care use & 10-fold higher direct
costs than NWRA
Diagnostic tools for
Occupational Asthma
 Specific inhalation challenge ( standard test)
 Combination of Peak Expiratory Flow Rate &
sputum eosinophil count
 Exhaled Breath Condensate pH test
l
Aims
 To characterize the threshold duration of
exposure needed to elicit an asthmatic
reaction during specific inhalation challenge
with various occupational agents
 To determine the duration of exposure that
should be complete before the test can be
considered negative
Materials & Methods
 A retrospective study
 Centre Hospitalier Universitaire de Mont-
Godinne, Universite Catholique de Louvain,
Yvain,Belgium
 From Jan 1992-Dec 2011
 Data records were reviewed
 All subjects investigated for possible occupational
asthma with positive test for specific inhalation
challenge
Materials & Methods
 Specific Inhalation Challenge:
- Occupational agents were generated in five-cubic-
meter cubicles using a realistic approach
- Asthma medications were stopped according to their
duration of action
- Inhaled steroid was halted 72 hr prior to the test
- The level of exposure during SICs was monitored
only for isocyanates using an MDA 7100 monitor
( MDA Scienctific Inc, Glenview, IL) & was kept below
the ceiling value of 20 ppb.
Materials & Methods
 Spirometry was obtained at:
- baseline, q 15 min * 4 times
q 30 min * 2 times
q 1 hr for a total of 6 hr after the end of exposure
- The baseline level of BHR to histamine & sputum eosinophil
count were assessed at the end of control day
- Re-assessed 6 & 24 hr after the active challenge
- Degree of non-specific BHR was assessed as provocative
concentration of histamine causing a 20% fall in FEV1 ( PC20)
- Positive SIC : sustained > 20% fall in FEV1 was recorded on 2
consecutive assessments
Materials & Methods
 On the first day :
- Using “ control” agent for 30 min to ensure
FEV1 fluctuation < 12% of baseline
- “ control” agent according to the nature of
occupational agent suspected causing asthma
( ie ; use lactose powder for flour)
Materials & Methods
 The second day:
- Use a suspected agent
- A duration of exposure gradually increased
from 1 , 4, 10, 15, 30, 60 min until a > 20%
fall in FEV1 occurred or 2 hr was reached
- Who did not show a >20% fall in FEV1, had to
repeat for 3 hr on the next day
- Negative test : challenging at least 240 min
without significant change
- If > 3-fold decrease in post-challenge PC20 or
increase in sputum > 3% compared to control
value, further challenge will be repeated
Conclusion
 Sensitivity of Specific Inhalation
Challenge for diagnosis occupational
asthma depend on duration of challenge
exposure
 Need markers such as post-challenge
level of non-specific bronchial
responsiveness to histamine , sputum
eosinophil count
Aim
 To evaluate the utility of exhaled breath
condensate ( EBC) pH for the diagnosis
of occupational asthma
Materials & Methods
 A prospective study
 Total of 37 patients suspected
occupational asthma
 Exclusion criteria:
- Seasonal asthma
- Can not join PEF, SIC, EBC pH
* Allow to take asthma medication but
don’t change type or dose
Materials & Methods
 Spirometry & Methacholine Test
- A Datospir 200 system ( Sibel, Barcelona, Spain) used for spirometry
- A Mefar MB3 dosimeter ( Ele H2O, Medically, Brescia, Italy) for
Methacholine test
- Increasing dose of methacholine ( 0.03-16 mg/ml) were inhaled at 3-
min intervals until FEV1 fell by 20% of baseline or max dose was
inhaled ( PC 20)
- Negative test defined as PC20 > 16 mg/ml
- Dose response rate : last FEV1 decline ( %) / last dose administered
Materials & Methods
 Monitoring Peak Expiratory Flow Rates
- Serial PEF during 2 wk at work & 2 wk off work
- A Mini-Wright portable peak flow meter ( Clement
Clarke International, UK) & diary cards
- Record 4 times a day
- PEF graphs were interpreted by 3 experienced
independent readers
- Positive test : evidence changes between exposure
period
- PEF recording was computerized by Oasys-2 software
- Suggestive Occupational asthma : score > 2.51
Materials & Methods
 Exhaled Breath Condensate Collection & pH Measurement
- Collecting during tidal breating with a commercially
condensor ( EcoScreen; Jaeger,Wurzburg, Germany)
- To determine ventilatory pattern, spirometer
( EcoVent; Jaeger ) was connected
- Patients were prohibited from foods 2 hr before sample
collection
- A fixed volume of 150 liters of exhaled breath was collected
per patient
- Sample was divided into 500 ul aliquots in 2-4 plastic tubes
Materials & Methods
 pH was measured in 1 aliquot after collection
immediately
 Another one was measured after de-aeration
with helium ( 350ml/min for 10 min)
 Using a model GLP 21 calibrated Ph meter
( Crison Instruments SA, Barcelona, Spain)
with an accuracy of +- 0.01 pH
 A probe ( Crison 5028) was calibrated daily
with standard Ph 7.02 & 4.00 buffers
Materials & Methods
 Specific Inhalation Challenge:
- Standard test for diagnosis
- Using substances suspected the cause of the patient’s
asthma*
- A placebo was done before an actual test
- Measuring FEV1, FVC q 10 min during first hr following
exposure & q 1 hr until 15 hr post-inhalation
- Positive test : FEV1 decrease > 20% baseline
j
Conclusion
 SIC is a gold standard to diagnosis
occupational asthma
 EBC pH is an easily performed,
inexpensive, & noninvasive method
 If SIC can’t be done, PEF & induced
sputum eosinophil count are chosen
 EBC pH alone or combine with PEF may
be a good option
Thank You Very Much

Weitere ähnliche Inhalte

Was ist angesagt?

Asbestos related lung disease
Asbestos related lung diseaseAsbestos related lung disease
Asbestos related lung diseaseKamal Bharathi
 
Assessment of CAP Severity by Pneumonia Scores
Assessment of CAP Severity by Pneumonia ScoresAssessment of CAP Severity by Pneumonia Scores
Assessment of CAP Severity by Pneumonia ScoresGamal Agmy
 
Occupational lung diseases
Occupational lung diseasesOccupational lung diseases
Occupational lung diseasesAshutosh Pakale
 
Occupational lung diseases –general principles and approaches and beryllosis ...
Occupational lung diseases –general principles and approaches and beryllosis ...Occupational lung diseases –general principles and approaches and beryllosis ...
Occupational lung diseases –general principles and approaches and beryllosis ...Mahmoud Elhusseiny Abolmagd
 
Asbestos&Berylliosis
Asbestos&BerylliosisAsbestos&Berylliosis
Asbestos&BerylliosisPrasad CSBR
 
BYSSINOSIS
BYSSINOSISBYSSINOSIS
BYSSINOSISshinz07
 
Dyspnoea & Respiratory Failure
Dyspnoea & Respiratory FailureDyspnoea & Respiratory Failure
Dyspnoea & Respiratory FailureMuhammad Helmi
 
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...martinshaji
 
Wallgren timetable of primary tb
Wallgren timetable of primary tbWallgren timetable of primary tb
Wallgren timetable of primary tbYapa
 
Occupational lung diseases
Occupational lung diseasesOccupational lung diseases
Occupational lung diseasesDwiKartikaRukmi
 

Was ist angesagt? (20)

Pneumoconiosis
Pneumoconiosis Pneumoconiosis
Pneumoconiosis
 
Coal worker's pneumoconiosis
Coal worker's pneumoconiosisCoal worker's pneumoconiosis
Coal worker's pneumoconiosis
 
Work Related Asthma
Work Related AsthmaWork Related Asthma
Work Related Asthma
 
Asbestos related lung disease
Asbestos related lung diseaseAsbestos related lung disease
Asbestos related lung disease
 
Byssinosis
ByssinosisByssinosis
Byssinosis
 
Assessment of CAP Severity by Pneumonia Scores
Assessment of CAP Severity by Pneumonia ScoresAssessment of CAP Severity by Pneumonia Scores
Assessment of CAP Severity by Pneumonia Scores
 
Occupational lung diseases
Occupational lung diseasesOccupational lung diseases
Occupational lung diseases
 
Occupational lung diseases –general principles and approaches and beryllosis ...
Occupational lung diseases –general principles and approaches and beryllosis ...Occupational lung diseases –general principles and approaches and beryllosis ...
Occupational lung diseases –general principles and approaches and beryllosis ...
 
Pneumoconiosis
PneumoconiosisPneumoconiosis
Pneumoconiosis
 
Pulmonary function test, bronchial challenge test, and FeNO.pdf
Pulmonary function test, bronchial challenge test, and FeNO.pdfPulmonary function test, bronchial challenge test, and FeNO.pdf
Pulmonary function test, bronchial challenge test, and FeNO.pdf
 
Pneumoconiosis
PneumoconiosisPneumoconiosis
Pneumoconiosis
 
Asbestos&Berylliosis
Asbestos&BerylliosisAsbestos&Berylliosis
Asbestos&Berylliosis
 
Approach to chronic cough
Approach to chronic coughApproach to chronic cough
Approach to chronic cough
 
BYSSINOSIS
BYSSINOSISBYSSINOSIS
BYSSINOSIS
 
Dyspnoea & Respiratory Failure
Dyspnoea & Respiratory FailureDyspnoea & Respiratory Failure
Dyspnoea & Respiratory Failure
 
Asbestos
AsbestosAsbestos
Asbestos
 
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
 
Wallgren timetable of primary tb
Wallgren timetable of primary tbWallgren timetable of primary tb
Wallgren timetable of primary tb
 
Fungal diseases of lung
Fungal diseases of lungFungal diseases of lung
Fungal diseases of lung
 
Occupational lung diseases
Occupational lung diseasesOccupational lung diseases
Occupational lung diseases
 

Ähnlich wie Occupational asthma

Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020Mohamed Metwally
 
COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021Dr. Mishal Saleem
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsShubham Kolge
 
Early Phase Pharmacodynamic Models For Respiratory Drug Candidates
Early Phase Pharmacodynamic Models For Respiratory Drug CandidatesEarly Phase Pharmacodynamic Models For Respiratory Drug Candidates
Early Phase Pharmacodynamic Models For Respiratory Drug CandidatesSGS
 
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...IndusTox Consult
 
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...Saleem Hamilah , RCP , MsRC
 
Exercise induced asthma &bronchospasm
Exercise induced asthma &bronchospasmExercise induced asthma &bronchospasm
Exercise induced asthma &bronchospasmFawzia Abo-Ali
 
Ventilator-Associated Event (VAE2)
Ventilator-Associated Event (VAE2)Ventilator-Associated Event (VAE2)
Ventilator-Associated Event (VAE2)Ahmed AlGahtani, RRT
 
Asthma attack reatment abreviated
Asthma  attack reatment abreviatedAsthma  attack reatment abreviated
Asthma attack reatment abreviatedMohamedKhamis77
 
How to do Spirometry in the Workplace
How to do Spirometry in the WorkplaceHow to do Spirometry in the Workplace
How to do Spirometry in the WorkplaceJane Coombs
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing pptWaseem MD abdul
 
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptx
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptxCARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptx
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptxsarika yadav
 
Antipyretic - pharmacological and toxicological screening methods
Antipyretic - pharmacological and toxicological screening methodsAntipyretic - pharmacological and toxicological screening methods
Antipyretic - pharmacological and toxicological screening methodsPriyashreeK1
 
9.1 Jongeneelen
9.1 Jongeneelen9.1 Jongeneelen
9.1 JongeneelenKate Jones
 
Reactive airway obstruction in children detection management_2018_pmm
Reactive airway obstruction  in children detection management_2018_pmmReactive airway obstruction  in children detection management_2018_pmm
Reactive airway obstruction in children detection management_2018_pmmParthiv Mehta
 
02 therapy and patient care number 2
02 therapy and patient care number 202 therapy and patient care number 2
02 therapy and patient care number 2Christina Ulrich
 
Medical evaluation respiratory protection program
Medical evaluation respiratory protection programMedical evaluation respiratory protection program
Medical evaluation respiratory protection programladdha1962
 

Ähnlich wie Occupational asthma (20)

Acute severe Asthma case presentation
Acute severe Asthma case presentationAcute severe Asthma case presentation
Acute severe Asthma case presentation
 
Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020
 
COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021
 
Espirometria gd
Espirometria gdEspirometria gd
Espirometria gd
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
Early Phase Pharmacodynamic Models For Respiratory Drug Candidates
Early Phase Pharmacodynamic Models For Respiratory Drug CandidatesEarly Phase Pharmacodynamic Models For Respiratory Drug Candidates
Early Phase Pharmacodynamic Models For Respiratory Drug Candidates
 
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...
Limit value for urinary 1-hydroxypyrene as marker of occupational exposure to...
 
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...
Asthma Part 2 - Diagnosis, Evaluation, Phenotypes, Occupational Asthma_Khuran...
 
Exercise induced asthma &bronchospasm
Exercise induced asthma &bronchospasmExercise induced asthma &bronchospasm
Exercise induced asthma &bronchospasm
 
Ventilator-Associated Event (VAE2)
Ventilator-Associated Event (VAE2)Ventilator-Associated Event (VAE2)
Ventilator-Associated Event (VAE2)
 
Asthma attack reatment abreviated
Asthma  attack reatment abreviatedAsthma  attack reatment abreviated
Asthma attack reatment abreviated
 
How to do Spirometry in the Workplace
How to do Spirometry in the WorkplaceHow to do Spirometry in the Workplace
How to do Spirometry in the Workplace
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing ppt
 
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptx
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptxCARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptx
CARE OF CHILD REQUIRING LONG TERM VENTILATOR.pptx
 
Antipyretic - pharmacological and toxicological screening methods
Antipyretic - pharmacological and toxicological screening methodsAntipyretic - pharmacological and toxicological screening methods
Antipyretic - pharmacological and toxicological screening methods
 
Synopsis
SynopsisSynopsis
Synopsis
 
9.1 Jongeneelen
9.1 Jongeneelen9.1 Jongeneelen
9.1 Jongeneelen
 
Reactive airway obstruction in children detection management_2018_pmm
Reactive airway obstruction  in children detection management_2018_pmmReactive airway obstruction  in children detection management_2018_pmm
Reactive airway obstruction in children detection management_2018_pmm
 
02 therapy and patient care number 2
02 therapy and patient care number 202 therapy and patient care number 2
02 therapy and patient care number 2
 
Medical evaluation respiratory protection program
Medical evaluation respiratory protection programMedical evaluation respiratory protection program
Medical evaluation respiratory protection program
 

Mehr von Chulalongkorn Allergy and Clinical Immunology Research Group

Mehr von Chulalongkorn Allergy and Clinical Immunology Research Group (20)

Asthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypesAsthma part 1: pathogenesis, diagnosis, and endotypes
Asthma part 1: pathogenesis, diagnosis, and endotypes
 
Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024Cat and dog allergy and exotic pets 2024
Cat and dog allergy and exotic pets 2024
 
Anti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiencyAnti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiency
 
DRESS syndrome.pdf
DRESS syndrome.pdfDRESS syndrome.pdf
DRESS syndrome.pdf
 
Wheat allergy.pdf
Wheat allergy.pdfWheat allergy.pdf
Wheat allergy.pdf
 
Indoor allergen avoidance.pdf
Indoor allergen avoidance.pdfIndoor allergen avoidance.pdf
Indoor allergen avoidance.pdf
 
Hymenoptera sting allergy.pdf
Hymenoptera sting allergy.pdfHymenoptera sting allergy.pdf
Hymenoptera sting allergy.pdf
 
AERD and NSAID hypersensitivity
AERD and NSAID hypersensitivityAERD and NSAID hypersensitivity
AERD and NSAID hypersensitivity
 
Food immunotherapy.pdf
Food immunotherapy.pdfFood immunotherapy.pdf
Food immunotherapy.pdf
 
Agammaglobulinemia.pdf
Agammaglobulinemia.pdfAgammaglobulinemia.pdf
Agammaglobulinemia.pdf
 
Histamine and anti histamines.pdf
Histamine and anti histamines.pdfHistamine and anti histamines.pdf
Histamine and anti histamines.pdf
 
Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis Food-dependent, exercise-induced anaphylaxis
Food-dependent, exercise-induced anaphylaxis
 
Beta-lactam allergy.pdf
Beta-lactam allergy.pdfBeta-lactam allergy.pdf
Beta-lactam allergy.pdf
 
Immunoglobulin therapy
Immunoglobulin therapyImmunoglobulin therapy
Immunoglobulin therapy
 
Local anesthetic drug allergy.pdf
Local anesthetic drug allergy.pdfLocal anesthetic drug allergy.pdf
Local anesthetic drug allergy.pdf
 
Iodinated contrast media Hypersensitivity
Iodinated contrast media HypersensitivityIodinated contrast media Hypersensitivity
Iodinated contrast media Hypersensitivity
 
Urticaria.pdf
Urticaria.pdfUrticaria.pdf
Urticaria.pdf
 
Serum sickness & SSLR
Serum sickness & SSLRSerum sickness & SSLR
Serum sickness & SSLR
 
Vaccine Hypersensitivity.pdf
Vaccine Hypersensitivity.pdfVaccine Hypersensitivity.pdf
Vaccine Hypersensitivity.pdf
 
HyperIgM syndrome.pdf
HyperIgM syndrome.pdfHyperIgM syndrome.pdf
HyperIgM syndrome.pdf
 

Kürzlich hochgeladen

Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 

Kürzlich hochgeladen (20)

Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 

Occupational asthma

  • 2. Overview  Definition  Etiology  Diagnosis  Conclusion
  • 3. Occupational Asthma ( OA) Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition. 939-953. -A type of asthma caused by the workplace -Classified into 2 types: 1. OA with a latency period need to get sensitized to an agent in the workplace 2. OA without a latency period, occur after accidentally inhale at work -Of the first type, mostly caused by high ( protein) molecular-weight agents -High-molecular weight agent induced by IgE- mediated mechanism - LMW agents act as hapten
  • 4. Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition. 939-953.
  • 5. l Jean Luc Malo & Moira Chan-Yeung. Occupational Asthma. In Middleton 7th edition. 939-953.
  • 7. Aims 1. Compare the clinical , functional and inflammatory characteristics of workers with work-exacerbated asthma and occupational asthma 2. Compare health care use and related costs between work-exacerbated asthma and occupational asthma, work-related asthma and non-work-related asthma JACI 2013; 131: 704-10
  • 8. Materials & Methods  A prospective cohort study with a 2-year follow- up  Subjects: - Asthmatic patients referred for suspected work-related asthma - Two tertiary centers in Quebec, Canada - From 2003-2008 JACI 2013; 131: 704-10
  • 9. Materials & Methods  Subjects : - At first visit ; questionnaires, SPT, PFT, methacholine inhalation challenge test, sputum induction - Be classified as ; inflammatory phenotypes - Eosiophilic ( sputum EO > 3%) - Nutrophilic ( sputum N > 61%) - Paucigranulocytic ( sputum EO< 3%,N < 61%) - Mixed ( sputum EO> 3% , N > 61%)
  • 10. Materials & Methods  Severe asthma: an ER visit or a hospitalization  Specific inhalation challenges to occupational agents were done when asthma possibly related to work  Asthma diagnosis: - FEV1<80% of predicted value - FEV1/FVC < 0.7 - improvement in FEV1 > 12% after bronchodilator - If absence of reversible airflow limitation, PC20 value should < 16 mg/ml JACI 2013; 131: 704-10
  • 11. Materials & Methods  Diagnosis of occupational asthma: - Positive specific inhalation challenge test - Worsening asthma symptoms while at work Diagnosis of work-exacerbation asthma: - Negative specific inhalation challenge test - Worsening asthma symptoms while at work
  • 12. Materials & Methods  Health care use and related costs - From administrative database - Focusing on physician’s cost, ER visit & hospitalization
  • 13. JACI 2013; 131: 704-10
  • 14. JACI 2013; 131: 704-10
  • 15. JACI 2013; 131: 704-10
  • 16. JACI 2013; 131: 704-10
  • 17. JACI 2013; 131: 704-10
  • 18. JACI 2013; 131: 704-10
  • 19. Conclusion  Workers with WEA have more severe clinical than workers with occupational asthma  WEA is associated with a non-eosinophilic phenotype  Both WEA & occupational asthma have greater health care use & 10-fold higher direct costs than NWRA
  • 20. Diagnostic tools for Occupational Asthma  Specific inhalation challenge ( standard test)  Combination of Peak Expiratory Flow Rate & sputum eosinophil count  Exhaled Breath Condensate pH test
  • 21. l
  • 22. Aims  To characterize the threshold duration of exposure needed to elicit an asthmatic reaction during specific inhalation challenge with various occupational agents  To determine the duration of exposure that should be complete before the test can be considered negative
  • 23. Materials & Methods  A retrospective study  Centre Hospitalier Universitaire de Mont- Godinne, Universite Catholique de Louvain, Yvain,Belgium  From Jan 1992-Dec 2011  Data records were reviewed  All subjects investigated for possible occupational asthma with positive test for specific inhalation challenge
  • 24. Materials & Methods  Specific Inhalation Challenge: - Occupational agents were generated in five-cubic- meter cubicles using a realistic approach - Asthma medications were stopped according to their duration of action - Inhaled steroid was halted 72 hr prior to the test - The level of exposure during SICs was monitored only for isocyanates using an MDA 7100 monitor ( MDA Scienctific Inc, Glenview, IL) & was kept below the ceiling value of 20 ppb.
  • 25. Materials & Methods  Spirometry was obtained at: - baseline, q 15 min * 4 times q 30 min * 2 times q 1 hr for a total of 6 hr after the end of exposure - The baseline level of BHR to histamine & sputum eosinophil count were assessed at the end of control day - Re-assessed 6 & 24 hr after the active challenge - Degree of non-specific BHR was assessed as provocative concentration of histamine causing a 20% fall in FEV1 ( PC20) - Positive SIC : sustained > 20% fall in FEV1 was recorded on 2 consecutive assessments
  • 26. Materials & Methods  On the first day : - Using “ control” agent for 30 min to ensure FEV1 fluctuation < 12% of baseline - “ control” agent according to the nature of occupational agent suspected causing asthma ( ie ; use lactose powder for flour)
  • 27. Materials & Methods  The second day: - Use a suspected agent - A duration of exposure gradually increased from 1 , 4, 10, 15, 30, 60 min until a > 20% fall in FEV1 occurred or 2 hr was reached - Who did not show a >20% fall in FEV1, had to repeat for 3 hr on the next day - Negative test : challenging at least 240 min without significant change - If > 3-fold decrease in post-challenge PC20 or increase in sputum > 3% compared to control value, further challenge will be repeated
  • 28.
  • 29.
  • 30. Conclusion  Sensitivity of Specific Inhalation Challenge for diagnosis occupational asthma depend on duration of challenge exposure  Need markers such as post-challenge level of non-specific bronchial responsiveness to histamine , sputum eosinophil count
  • 31.
  • 32. Aim  To evaluate the utility of exhaled breath condensate ( EBC) pH for the diagnosis of occupational asthma
  • 33. Materials & Methods  A prospective study  Total of 37 patients suspected occupational asthma  Exclusion criteria: - Seasonal asthma - Can not join PEF, SIC, EBC pH * Allow to take asthma medication but don’t change type or dose
  • 34.
  • 35. Materials & Methods  Spirometry & Methacholine Test - A Datospir 200 system ( Sibel, Barcelona, Spain) used for spirometry - A Mefar MB3 dosimeter ( Ele H2O, Medically, Brescia, Italy) for Methacholine test - Increasing dose of methacholine ( 0.03-16 mg/ml) were inhaled at 3- min intervals until FEV1 fell by 20% of baseline or max dose was inhaled ( PC 20) - Negative test defined as PC20 > 16 mg/ml - Dose response rate : last FEV1 decline ( %) / last dose administered
  • 36. Materials & Methods  Monitoring Peak Expiratory Flow Rates - Serial PEF during 2 wk at work & 2 wk off work - A Mini-Wright portable peak flow meter ( Clement Clarke International, UK) & diary cards - Record 4 times a day - PEF graphs were interpreted by 3 experienced independent readers - Positive test : evidence changes between exposure period - PEF recording was computerized by Oasys-2 software - Suggestive Occupational asthma : score > 2.51
  • 37. Materials & Methods  Exhaled Breath Condensate Collection & pH Measurement - Collecting during tidal breating with a commercially condensor ( EcoScreen; Jaeger,Wurzburg, Germany) - To determine ventilatory pattern, spirometer ( EcoVent; Jaeger ) was connected - Patients were prohibited from foods 2 hr before sample collection - A fixed volume of 150 liters of exhaled breath was collected per patient - Sample was divided into 500 ul aliquots in 2-4 plastic tubes
  • 38.
  • 39. Materials & Methods  pH was measured in 1 aliquot after collection immediately  Another one was measured after de-aeration with helium ( 350ml/min for 10 min)  Using a model GLP 21 calibrated Ph meter ( Crison Instruments SA, Barcelona, Spain) with an accuracy of +- 0.01 pH  A probe ( Crison 5028) was calibrated daily with standard Ph 7.02 & 4.00 buffers
  • 40. Materials & Methods  Specific Inhalation Challenge: - Standard test for diagnosis - Using substances suspected the cause of the patient’s asthma* - A placebo was done before an actual test - Measuring FEV1, FVC q 10 min during first hr following exposure & q 1 hr until 15 hr post-inhalation - Positive test : FEV1 decrease > 20% baseline
  • 41. j
  • 42.
  • 43.
  • 44.
  • 45. Conclusion  SIC is a gold standard to diagnosis occupational asthma  EBC pH is an easily performed, inexpensive, & noninvasive method  If SIC can’t be done, PEF & induced sputum eosinophil count are chosen  EBC pH alone or combine with PEF may be a good option